Trek Diagnostic Systems, a Cleveland-based provider of blood culture, identification, and susceptibility technologies, was acquired by
Thermo Fisher Scientific. Trek has 160 employees, 2010 revenue of $34 million, and serves the global pharmaceutical and clinical laboratory markets. The acquisition augments Thermo Fisher Scientific's portfolio of microbiologial testing technologies.
Click here to read more from Crain's Cleveland.